Digital chronic-condition management company Lark Health announced the appointment of Darren Eckberg as its new chief growth officer, who will lead the expansion of the company's AI-enabled GLP-1 cost-containment technology.
The company offers health plans and employers technology aimed at reducing the costs associated with GLP-1s, including virtual coaching for weight management and medication...
Digital diabetes management company Glooko has acquired Paris-based DIABNEXT, a fellow diabetes care platform.
DIABNEXT's app tracks patient diabetes metrics, allowing providers to monitor that data and provide care remotely. Glooko said it will offer its own platform and DIABNEXT, rebranded as Glooko XT, for the French market.
"We are very pleased to welcome the DIABNEXT team to Glooko and...
Digital chronic condition management company Lark Health has closed a Series D funding round worth $100 million.
Deerfield Management Company led the raise, with participation from PFM Health Sciences and returning investors Franklin Templeton, King River Capital, Castlepeak, IPD, Olive Tree Capital and Marvell Technology cofounder Weili Dai.
With the money from its Series D round, Lark’s total...
Digital chronic care management tool Lark Health scooped up $55 million in its Series C round. In addition to the venture funding, the company added another $15 million through venture debt credit.
Kind River Capital led the round with participation from Franklin Templeton, SteelSky Ventures, Olive Tree Capital, Lightspeed Ventures, Asset Management Ventures and individual investors.
The...
With an eye on prevention, chronic care management startup Lark Health revealed exclusively to MobiHealthNews that it is launching a new AI-enabled program targeted at keeping at-risk patients healthy.
Dubbed Lark Prevention, the tool was created to help guide Lark Health's members through behavioral coaching to address weight management, smoking cessation, stress and overall general health....
Telehealth and mail-order health and wellness consumer brands Hims & Hers have been joined by Dr. Pat Carroll. Formerly a chief medical officer at Walgreens and a 20,000-patient primary care group, Carroll take on a similar role for the growing startup.
“Our vision is an ecosystem where people have plenty of options to get the care that’s right for them. Depending on what they need, that...
Door closes on drug discovery. IBM is tapering off sales of its Watson for Drug Discovery product in favor of other healthcare offerings using the AI technology, STAT reported this morning. The decision was made in response to weak demand and purchases from customers.
"We are focusing our resources within Watson Health to double down on the adjacent field of clinical development where we see an...
At SXSW in Austin this weekend, consumer genomics company 23andMe unveiled its latest test, a predisposition report on Type 2 diabetes.
The test, which has not undergone FDA clearance and does not purport to diagnose a condition, is designed to help people understand when they’re at a higher-than-normal risk for Type 2 diabetes so they can alter their lifestyle. To assist with the latter piece,...
This morning, consumer genomic giant 23andMe revealed that it is teaming up with Lark Health, an AI platform that helps users manage chronic conditions, on a new initiative that will integrate a user’s 23andMe genetic information into Lark’s Wellness Program and Diabetes Prevention Program. The idea is that Lark’s AI weight loss and wellness coach will be able to access a user’s genetic...
Udi Manber, a veteran of Amazon, Yahoo and, most recently, Google, has been hired by Anthem, CNBC reports. Specifically, Manber will be building and leading a team focused on artificial intelligence applications, signifying an increasing interest in the technology for the large health insurer.
Manber held the title of vice president of engineering at Google and was largely responsible for its...
_16e415.jpg?itok=W9Rpj_tO)
